Latest News
Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials
OXFORD, England-- Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for immuno-oncology to enter human clinical trials. The...
Pharma
Public Health
COVID-19 Statistics
United States
575,593
Total deaths
Updated on April 10, 2021 10:58 pm
- Advertisement -
Real Estate
Architect Matthew Fickett on Designing and Scaling Up Labs for Academic and Commercial Sector
19:07
Coworking Space is Not Dead; In Fact, it is Thriving for Workbar
18:11
WS Development’s Brian Sciera Bullish on Retail Real Estate Despite Current Pandemic
16:08
Real Estate Times Honors 10 Outstanding Women Leaders & Some Straight Talk on Gender and Empowerment
01:00:30
BioMed Realty's Bill Kane Talks About Acquisition of Assembly Square Site and Life Sciences Boom
14:01
Thomas O'Brien on Boston’s Newest Luxury High-Rise Residential Tower, Bulfinch Crossing and 2021
16:43
Jennifer Francis, President of Diversified Healthcare Trust and RMR Group EVP, on Real Estate Today
17:43
CBT’s Maren Reepmeyer on Asset Strategy, Repositioning, Adaptive Design and Other Trends
17:00
Cain International VP Matt Gralla on Boston and US Investment Market During the Pandemic and Beyond
16:14
Antiquated Intercom, Building Security Technologies and Historic Brownstones & Commercial Buildings
17:15
Recent Comments